Business Context and Reporting Period
This Form 8-K filing by Diodes Incorporated (Diodes Inc.) reports on executive and board compensation decisions made on June 6, 2013. The report follows the Company's annual stockholder meeting held on May 29, 2013, where the 2013 Equity Incentive Plan was approved.
Key Financial Metrics
This filing does not contain revenue, profit, cash flow, margin, debt, or liquidity metrics. It focuses exclusively on executive and director compensation arrangements.
Material Changes and Compensation Details
Executive Compensation
Effective June 1, 2013, the Compensation Committee determined base salaries and granted non-qualified stock options (NQSOs) and restricted stock units (RSUs) to Named Executive Officers (NEOs). The NQSOs have an exercise price of $23.35 (closing price on June 6, 2013) and vest in four equal annual installments starting July 1, 2014.
| Name and Position | Base Salary | NQSOs Granted | RSUs Granted |
|---|---|---|---|
| Dr. Keh-Shew Lu (President and CEO) | $527,000 | 80,000 | 80,000 |
| Richard D. White (CFO, Secretary, Treasurer) | $320,000 | 25,000 | 11,000 |
| Mark A. King (SVP, Sales and Marketing) | $320,000 | 23,000 | 10,000 |
| Joseph Liu (SVP, Operations) | $320,000 | 10,000 | 10,000 |
| Edmund Tang (VP, Corporate Administration) | $290,000 | 10,000 | 10,000 |
Board Compensation
Board compensation remained unchanged for 2013. Annual cash retainers are $80,000 for non-employee directors, with additional retainers of $20,000 for the Chairman and $10,000 for Audit Committee members. Annual RSU awards were granted on June 6, 2013, vesting over four years:
- Chairman of the Board: 21,500 shares
- Vice Chairman of the Board: 14,700 shares
- Other non-employee directors: 4,300 shares
Guidance, Outlook, and Risks
The filing contains no financial guidance, outlook, or discussion of risks and contingencies. It notes that the Board of Directors may modify director compensation in the future.
Key Facts for Investor Verification
- Verify the vesting schedule for the 2013 equity grants (four equal annual installments commencing July 1, 2014).
- Confirm the exercise price of the NQSOs ($23.35) against the market price on June 6, 2013.
- Review the full text of the 2013 Equity Incentive Plan filed as Appendix A to the Definitive Proxy Statement (Schedule 14A) filed on April 19, 2013.
- Note that this filing does not provide operational or financial performance data for the period.